Previous Close | 28.92 |
Open | 29.04 |
Bid | 28.68 x 6200 |
Ask | 28.84 x 6200 |
Day's Range | 28.80 - 30.10 |
52 Week Range | 21.82 - 36.98 |
Volume | |
Avg. Volume | 16 |
Market Cap | 740.629M |
Beta (5Y Monthly) | 1.34 |
PE Ratio (TTM) | 46.45 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MINNEAPOLIS, May 03, 2024--Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the first quarter ended March 31, 2024.
MINNEAPOLIS, May 01, 2024--Protolabs (NYSE: PRLB) highlights its critical work with BioDapt, a company that designs, manufactures, and distributes high-performance lower limb prosthetic equipment used for action sports and other activities with similar physical demands. This is just one of the many ways Protolabs positively impacts the world through its unique, hybrid digital manufacturing model that combines its own digital factories with a network of global manufacturing partners.
MINNEAPOLIS, April 12, 2024--Protolabs (NYSE: PRLB) announced today that it will issue its financial results for the first quarter of 2024 before the opening of the market on May 3, 2024. Protolabs will host a conference call to discuss the results at 8:30 a.m. EDT on the same day. A simultaneous webcast of the call will be available via this link and at the investor relations section of the Protolabs website.